Facebook pixel

Senior Scientist
Analytical Development, CMC
Confirmed live in the last 24 hours
Locations
Vancouver, BC, Canada
Experience Level
Entry
Junior
Mid
Senior
Expert
Requirements
  • You are an innovator and ready to help new approaches to the discovery and development of therapeutics
  • You have a strong desire to support early antibody discovery work by developing ways to improve and speed up the discovery to CMC development to GMP manufacturing paradigm
  • You are ready to revolutionize therapeutic development and move at lightning speed to create a legacy in our industry
  • You are an outstanding communicator and teammate
  • You are highly motivated and excited about the opportunity to work with an inspired team on challenging problems that matter
  • Ph.D. and 5+ years of experience, M.Sc. and 8+ years of experience, or B.Sc. and 10+ years of experience
  • In-depth knowledge of immuno-assay development (Ex. ELISA), troubleshooting, and qualification
  • Familiarity with regulatory requirements as it pertains to CMC activities for monoclonal antibodies (FDA, EMA, ICH, etc)
  • Experience managing and mentoring a team of junior scientists
  • Demonstrated proficiency with molecular biology techniques including 1D-/2D-Gel Electrophoresis, Western blotting, qPCR, etc
  • Proficiency working with data acquisition platforms related to immunoassays (Ex. Softmax Pro)
  • A proven problem-solver and team player with strong written and verbal communication skills
  • Familiarity with electronic lab notebooks (Ex. Benchling), experimental data capture, and the associated 21 CFR part 11 compliance requirements
  • Knowledge of regulatory filings such as INDs, BLAs, IMPDs, etc would be advantageous
  • Understanding of regulatory requirements for biologics
Desired Qualifications
  • Experience with lab automation is a plus
  • Experience with CMC analytical development of monoclonal antibodies or related biotherapeutic proteins is a plus
AbCellera Biologics
Company Overview
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.